Retracted, A. (2017). EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS. Asian Journal of Pharmaceutical and Clinical Research, 10(3), 300–307. Retrieved from https://journals.innovareacademics.in/index.php/ajpcr/article/view/16213